These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 38062297)

  • 1. HOXA9 transcription factor is a double-edged sword: from development to cancer progression.
    Shenoy US; Adiga D; Alhedyan F; Kabekkodu SP; Radhakrishnan R
    Cancer Metastasis Rev; 2024 Jun; 43(2):709-728. PubMed ID: 38062297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer exploration of oncogenic and clinical impacts revealed that HOXA9 is a diagnostic indicator of tumorigenesis.
    Shenoy US; Basavarajappa DS; Kabekkodu SP; Radhakrishnan R
    Clin Exp Med; 2024 Jun; 24(1):134. PubMed ID: 38904676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia.
    Ni J; Zhou S; Yuan W; Cen F; Yan Q
    J Recept Signal Transduct Res; 2019; 39(5-6):399-406. PubMed ID: 31875764
    [No Abstract]   [Full Text] [Related]  

  • 4. HOXA9 is Underexpressed in Cervical Cancer Cells and its Restoration Decreases Proliferation, Migration and Expression of Epithelial-to-Mesenchymal Transition Genes.
    Alvarado-Ruiz L; Martinez-Silva MG; Torres-Reyes LA; Pina-Sanchez P; Ortiz-Lazareno P; Bravo-Cuellar A; Aguilar-Lemarroy A; Jave-Suarez LF
    Asian Pac J Cancer Prev; 2016; 17(3):1037-47. PubMed ID: 27039722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway.
    Liu Y; Wang Y; Yang H; Zhao L; Song R; Tan H; Wang L
    Int J Oncol; 2019 May; 54(5):1809-1820. PubMed ID: 30816476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9.
    Fu Z; Chen C; Zhou Q; Wang Y; Zhao Y; Zhao X; Li W; Zheng S; Ye H; Wang L; He Z; Lin Q; Li Z; Chen R
    Cancer Lett; 2017 Dec; 410():68-81. PubMed ID: 28947139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The twist box domain is required for Twist1-induced prostate cancer metastasis.
    Gajula RP; Chettiar ST; Williams RD; Thiyagarajan S; Kato Y; Aziz K; Wang R; Gandhi N; Wild AT; Vesuna F; Ma J; Salih T; Cades J; Fertig E; Biswal S; Burns TF; Chung CH; Rudin CM; Herman JM; Hales RK; Raman V; An SS; Tran PT
    Mol Cancer Res; 2013 Nov; 11(11):1387-400. PubMed ID: 23982216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXA9 mediates and marks premalignant compartment size expansion in colonic adenomas.
    Janmaat VT; Liu H; da Silva RA; Wisse PHA; Spaander MCW; Ten Hagen TLM; Smits R; Bruno MJ; Fuhler GM; Peppelenbosch MP
    Carcinogenesis; 2019 Dec; 40(12):1514-1524. PubMed ID: 31099823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
    Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
    Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear Factor-kappa B activity in non-small cell lung cancer cells.
    Yu SL; Lee DC; Sohn HA; Lee SY; Jeon HS; Lee JH; Park CG; Lee HY; Yeom YI; Son JW; Yoon YS; Kang J
    Mol Carcinog; 2016 Dec; 55(12):1915-1926. PubMed ID: 26586336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-to-mesenchymal transition: lessons from development, insights into cancer and the potential of EMT-subtype based therapeutic intervention.
    Antony J; Thiery JP; Huang RY
    Phys Biol; 2019 May; 16(4):041004. PubMed ID: 30939460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis.
    Gonçalves CS; Xavier-Magalhães A; Martins EP; Pinto AA; Pires MM; Pinheiro C; Reis RM; Sousa N; Costa BM
    Mol Oncol; 2020 Jun; 14(6):1224-1241. PubMed ID: 31923345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
    Nam EH; Lee Y; Park YK; Lee JW; Kim S
    Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic EMT: a multi-tool for tumor progression.
    Brabletz S; Schuhwerk H; Brabletz T; Stemmler MP
    EMBO J; 2021 Sep; 40(18):e108647. PubMed ID: 34459003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts.
    Ko SY; Barengo N; Ladanyi A; Lee JS; Marini F; Lengyel E; Naora H
    J Clin Invest; 2012 Oct; 122(10):3603-17. PubMed ID: 22945634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies.
    Shi Q; Xue C; Zeng Y; Yuan X; Chu Q; Jiang S; Wang J; Zhang Y; Zhu D; Li L
    Signal Transduct Target Ther; 2024 May; 9(1):128. PubMed ID: 38797752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Synthetic CPP33-Conjugated
    Yu SL; Koo H; Lee SI; Kang J; Han YH; Yeom YI; Lee DC
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33238593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
    Wierstra I
    Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.